Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status

Kevin K. Kumar, Cody R. Goodwin, Michael A. Uhouse, Julia Bornhorst, Tanja Schwerdtle, Michael Aschner, John A. McLean, Aaron B. Bowman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.

Original languageEnglish (US)
Pages (from-to)363-370
Number of pages8
JournalMetallomics
Volume7
Issue number2
DOIs
StatePublished - Mar 1 2015

Fingerprint

Huntington Disease
Manganese
Corpus Striatum
Neurons
Metabolites
Brain
Pantothenic Acid
Pentoses
Pentose Phosphate Pathway
Metabolomics
Carnitine
Micronutrients
Liquid chromatography
Neurology
Pathology
Cytotoxicity
Basal Ganglia
Liquid Chromatography
Neurodegenerative Diseases
Nervous System

ASJC Scopus subject areas

  • Biomaterials
  • Metals and Alloys
  • Chemistry (miscellaneous)
  • Biochemistry
  • Biophysics

Cite this

Kumar, K. K., Goodwin, C. R., Uhouse, M. A., Bornhorst, J., Schwerdtle, T., Aschner, M., ... Bowman, A. B. (2015). Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics, 7(2), 363-370. https://doi.org/10.1039/c4mt00223g

Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. / Kumar, Kevin K.; Goodwin, Cody R.; Uhouse, Michael A.; Bornhorst, Julia; Schwerdtle, Tanja; Aschner, Michael; McLean, John A.; Bowman, Aaron B.

In: Metallomics, Vol. 7, No. 2, 01.03.2015, p. 363-370.

Research output: Contribution to journalArticle

Kumar, KK, Goodwin, CR, Uhouse, MA, Bornhorst, J, Schwerdtle, T, Aschner, M, McLean, JA & Bowman, AB 2015, 'Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status', Metallomics, vol. 7, no. 2, pp. 363-370. https://doi.org/10.1039/c4mt00223g
Kumar, Kevin K. ; Goodwin, Cody R. ; Uhouse, Michael A. ; Bornhorst, Julia ; Schwerdtle, Tanja ; Aschner, Michael ; McLean, John A. ; Bowman, Aaron B. / Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. In: Metallomics. 2015 ; Vol. 7, No. 2. pp. 363-370.
@article{1534e1a336234e84b475a601e9190bf3,
title = "Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status",
abstract = "Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.",
author = "Kumar, {Kevin K.} and Goodwin, {Cody R.} and Uhouse, {Michael A.} and Julia Bornhorst and Tanja Schwerdtle and Michael Aschner and McLean, {John A.} and Bowman, {Aaron B.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1039/c4mt00223g",
language = "English (US)",
volume = "7",
pages = "363--370",
journal = "Metallomics",
issn = "1756-5901",
publisher = "Royal Society of Chemistry",
number = "2",

}

TY - JOUR

T1 - Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status

AU - Kumar, Kevin K.

AU - Goodwin, Cody R.

AU - Uhouse, Michael A.

AU - Bornhorst, Julia

AU - Schwerdtle, Tanja

AU - Aschner, Michael

AU - McLean, John A.

AU - Bowman, Aaron B.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.

AB - Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=84923105977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923105977&partnerID=8YFLogxK

U2 - 10.1039/c4mt00223g

DO - 10.1039/c4mt00223g

M3 - Article

C2 - 25599126

AN - SCOPUS:84923105977

VL - 7

SP - 363

EP - 370

JO - Metallomics

JF - Metallomics

SN - 1756-5901

IS - 2

ER -